{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:45:08Z","timestamp":1782711908133,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100015690","name":"Universitas Padjadjaran","doi-asserted-by":"publisher","award":["1549\/UN6.3.1\/PT.00\/2023"],"award-info":[{"award-number":["1549\/UN6.3.1\/PT.00\/2023"]}],"id":[{"id":"10.13039\/501100015690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-026-01144-z","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:05:20Z","timestamp":1782709520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nephrin\u2013IgG co-localization expression in pediatric steroid-resistant nephrotic syndrome: a case series from Indonesia"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3824-9365","authenticated-orcid":false,"given":"Rini","family":"Rossanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmedz","family":"Widiasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inoki","family":"Yuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"China","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asahi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoyama","family":"Shuhei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedi","family":"Rachmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"Hilmanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"1144_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/978-3-662-43596-0_24","volume-title":"Pediatric Nephrology","author":"P Niaudet","year":"2016","unstructured":"Niaudet P, Boyer O, et al. Idiopathic nephrotic syndrome in children: clinical aspects. In: Avner E, Harmon W, Niaudet P, Yoshikawa N, Emma F, Goldstein S, editors., et al., Pediatric Nephrology. 7 ed. US: Springer-Verlag; 2016. p. 839\u201382.","edition":"7 ed"},{"issue":"3","key":"1144_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"A Trautmann","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2023;38(3):877\u2013919.","journal-title":"Pediatr Nephrol"},{"key":"1144_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.974840","volume":"10","author":"M Najafi","year":"2022","unstructured":"Najafi M, Riedhammer KM, Rad A, Torbati PN, Berutti R, Sch\u00fcle I, et al. High detection rate for disease-causing variants in a cohort of 30 Iranian pediatric steroid resistant nephrotic syndrome cases. Front Pediatr. 2022;10:974840.","journal-title":"Front Pediatr"},{"key":"1144_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae218","volume":"17","author":"N Prasad","year":"2024","unstructured":"Prasad N, Meyyappan J, Dhanorkar M, Kushwaha R, Mandal K, Veeranki V, et al. Novel mutation patterns in children with steroid-resistant nephrotic syndrome. Clin Kidney J. 2024;17:sfae218.","journal-title":"Clin Kidney J"},{"issue":"1","key":"1144_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13052-024-01655-4","volume":"50","author":"X Cheng","year":"2024","unstructured":"Cheng X, Chen J, Yang X, Chan H, Yang X, Jiao J, et al. Comparison of different genetic testing modalities applied in paediatric patients with steroid resistant nephrotic syndrome. Ital J Pediatr. 2024;50(1):85.","journal-title":"Ital J Pediatr"},{"key":"1144_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304864","author":"S Li","year":"2024","unstructured":"Li S, Hu M, He C, Sun Y, Huang W, Lei F, et al. A multicenter study investigating the genetic analysis of childhood steroid-resistant nephrotic syndrome: Variants in COL4A5 may not be coincidental. PLoS ONE. 2024. https:\/\/doi.org\/10.1371\/journal.pone.0304864.","journal-title":"PLoS ONE"},{"issue":"3","key":"1144_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneph.2015.205","volume":"12","author":"A Vivante","year":"2016","unstructured":"Vivante A, Hildebrandt F. Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol. 2016;12(3):133\u201346.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1144_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ajhg.2014.11.014","volume":"96","author":"L Ebarasi","year":"2015","unstructured":"Ebarasi L, Ashraf S, Bierzynska A, Gee HY, McCarthy HJ, Lovric S, et al. Defects of CRB2 cause steroid-resistant nephrotic syndrome. Am J Hum Genet. 2015;96(1):153\u201361.","journal-title":"Am J Hum Genet"},{"issue":"7497","key":"1144_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature13127","volume":"508","author":"DG MacArthur","year":"2014","unstructured":"MacArthur DG, Manolio TA, Dimmock DP, Rehm HL, Shendure J, Abecasis GR, et al. Guidelines for investigating causality of sequence variants in human disease. Nat. 2014;508(7497):469\u201376.","journal-title":"Nat"},{"issue":"5","key":"1144_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"12","key":"1144_CR11","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00467-024-06468-5","volume":"39","author":"Y Ichikawa","year":"2024","unstructured":"Ichikawa Y, Sakakibara N, Nagano C, Inoki Y, Tanaka Y, Ueda C, et al. In steroid-resistant nephrotic syndrome that meets the strict definition, monogenic variants are less common than expected. Pediatr Nephrol. 2024;39(12):3497\u2013503.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"1144_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1681\/ASN.2021060794","volume":"33","author":"AJB Watts","year":"2022","unstructured":"Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, et al. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol. 2022;33(1):238\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1144_CR13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s10157-025-02645-4","volume":"29","author":"T Horinouchi","year":"2025","unstructured":"Horinouchi T, Nozu K, Iijima K. Genetic aspects of pediatric nephrotic syndrome and anti-nephrin antibodies. Clin Exp Nephrol. 2025;29(5):534\u201340.","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"1144_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.kint.2025.01.019","volume":"107","author":"FE Hengel","year":"2025","unstructured":"Hengel FE, Dehde S, Yilmaz A, Bayazit AK, Ozaltin F, Paripovic D, et al. Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy. Kidney Int. 2025;107(6):1099\u2013103.","journal-title":"Kidney Int"},{"key":"1144_CR15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314471","author":"FE Hengel","year":"2024","unstructured":"Hengel FE, Dehde ML, Zahner G, Seifert L, Schnarre A, Kretz O, et al. Autoantibodies targeting nephrin in podocytopathies. N Engl J Med. 2024. https:\/\/doi.org\/10.1056\/NEJMoa2314471.","journal-title":"N Engl J Med"},{"issue":"12","key":"1144_CR16","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s10157-025-02741-5","volume":"29","author":"Y Ichikawa","year":"2025","unstructured":"Ichikawa Y, Sakakibara N, Aoyama S, Kimura Y, Inoki Y, Tanaka Y, et al. Co-localization of IgG with nephrin in immune-mediated idiopathic nephrotic syndrome. Clin Exp Nephrol. 2025;29(12):1821\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"1144_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","volume":"6","author":"JB Kopp","year":"2020","unstructured":"Kopp JB, Anders HJ, Susztak K, Podest\u00e0 MA, Remuzzi G, Hildebrandt F, et al. Podocytopathies. Nat Rev Dis Primers. 2020;6(1):68.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1144_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal Change Disease. Clin J Am Soc Nephrol. 2017;12(2):332\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"25","key":"1144_CR19","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","volume":"365","author":"VD D'Agati","year":"2011","unstructured":"D\u2019Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med. 2011;365(25):2398\u2013411.","journal-title":"N Engl J Med"},{"issue":"2","key":"1144_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00441-021-03454-3","volume":"385","author":"F Braun","year":"2021","unstructured":"Braun F, Homeyer I, Alachkar N, Huber TB. Immune-mediated entities of (primary) focal segmental glomerulosclerosis. Cell Tissue Res. 2021;385(2):423\u201334.","journal-title":"Cell Tissue Res"},{"issue":"4","key":"1144_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S0272-6386(84)80043-8","volume":"3","author":"V Pardo","year":"1984","unstructured":"Pardo V, Riesgo I, Zilleruelo G, Strauss J. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome. Am J Kidney Dis. 1984;3(4):264\u20139.","journal-title":"Am J Kidney Dis"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01144-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-026-01144-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01144-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:05:21Z","timestamp":1782709521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-026-01144-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1007\/s13730-026-01144-z","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tomoko Horinouchi reports research funding from Sysmex Corporation, and Zenyaku Kogyo Co., Ltd. Kazumoto Iijima reports research grant from Zenyaku Kogyo Co., Ltd., Nippon Shinyaku Co., Ltd.; consulting fees from Kyowa Kirin Co., Ltd., Novartis Japan, Chugai Pharmaceutical Co., Ltd., Zenyaku Kogyo Co., Ltd.; lecture fee from Zenyaku Kogyo Co., Ltd., Novartis Japan; patents planned on the development of antisense nucleotides for exon skipping therapy in Alport syndrome. Kandai Nozu reports research funding from Toa Eiyo Ltd., Zenyaku Kogyo, Torii Co; consulting fees from Kyowa Kirin Co., Ltd., Toa Eiyo Ltd., Zenyaku Kogyo Co., Ltd., Taisho Pharmaceutical Co., Ltd.; lecture fee from Ono Pharma, Astellas Pharma, Novo Nordisk Pharma, Alexion Pharma, Sumitomo Pharma, Sanofi, Otsuka Pharma, Daiichi Sankyo, Miyarisan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (Research Ethics Committee Universitas Padjadjaran approval No.70\/UN6.KEP\/EC\/2025) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Comprehensive written informed consent was obtained from all individual participants included in the study and\/or their guardians for use of residual biopsied kidney samples and patients\u2019 clinical data, before renal biopsy. Consent for publication was not required, because the study was retrospective and previously stored kidney biopsy specimens were used for staining.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"113"}}